Featured on IU Impact, January 8, 2025 by Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office. Indiana University Bloomington students are diving into the life sciences industry by learning about its complexities and intricate network of relationships that aid in bringing innovative health solutions to market. IU undergraduate student Izzy Branam,… Read more »
Fall Kelley Life Sciences Course Delves Into Digital Therapeutics Startup- Leveraging Virtual Reality
Each fall the Kelley School’s Center for the Business of Life Sciences coordinates the X419 and X519 Life Sciences Industry from Research to Patient course for undergraduate and graduate business and science students. The course is taught by the CBLS Director, George Telthorst. The course includes over twenty guest lecturers from the industry as well… Read more »
Changes in the Healthcare Ecosystem Conference Yields Rich Discussion From Speakers & Attendees
Breaking Bottlenecks: Consumerism and Collaboration in Healthcare 🩺💻 Summary by Rex Rumsey, MBA Candidate, Class of ’25 What if the future of healthcare were reimagined? At the recent IU Kelley School of Business’ Indiana Life Sciences Collaboration focused on Healthcare, a dynamic keynote by Jay Bhatt of Deloitte followed by panelists– Conor Aberle, Eli Lilly… Read more »
Class 6- Supporting Products and Services
Life Sciences Industry from Research to Patient Class Supporting Products and Services – Contract Manufacturing, Specialized Raw Materials and Supplies, Regulatory and Reimbursement Consulting, Clinical Trial Design and Management, Medical Products Advertising and Marketing, & Contract Logistics By Rex Rumsey, MBA Candidate Class of ’25 Developing a Therapeutic is Step #1: Teamwork Brings Innovation to… Read more »
Kelley MBA’s Earn 2rd Place in Prestigious Gilead Pharma Case Competition!
Submission by Sandeep Singh Deora, MBA Candidate Class of ’25 From October 30th-November 13th our team of Kelley MBA’s; Sandeep Singh Deora, Nishad Joshi, Aakriti Goyal, and Loretta Renee`Abdul-Ghani competed in the 5th Annual Gilead Case Competition sponsored by Gilead Sciences, Inc. The Case brief was to develop a revenue diversification strategy for… Read more »
Class 5- Final Stage Services
By Rex Rumsey, MBA Candidate Class of ’25 2024 Fall Kelley Life Sciences Industry from Research to Patient Class December 3 Class 5: Final Stage Services – Profit and Non-profit Hospitals, Free-standing Treatment and Surgery Centers, Physician Practices, Insurers, Prescription Benefit Managers Healthcare Challenges & Innovations was the common thread of this class discussion. Healthcare… Read more »
Class 4- Final Products: Medical Devices
By Rex Rumsey, MBA Candidate Class of ’25 Fall 2024 Kelley Life Sciences Industry from Research to Patient Course November 19 Class 4: Final Products – Medical Devices: Measurement and Monitoring, Minimally and Less Invasive Therapies, Various Implants (cardio, orthopedic, other), Medical Tools and Supplies Growth Through Strategic Acquisitions and Private Equity in Healthcare was… Read more »
Class 3- Final Products
By Rex Rumsey, MBA Candidate Class of ’25 Kelley Fall 2024 Life Sciences Industryfrom Research to Patient Course November 12 Class 3: Final Products – Pharmaceuticals, Biologics, Generics and Biosimilars, Animal Pharma Incredible insights, yet again, at Kelley Life Sciences, thanks to Stephanie Maresh, Caleb Hart, and Mary Jensen! 🧬 MJ kicked off the evening… Read more »
Class 2- Long Term Research
By Rex Rumsey, MBA Candidate Class of ’25 Fall 2024 Kelley Life Sciences Industry from Research to Patient Course November 5 Class 2: Long-term Research – University vs. Non-university, In-house vs. Outsourced, the Balance – Basic Research vs. Product and Process Development and Commercialization, Financing/ Grants, Technology Transfer. Huge thanks to Labcorp, IU Innovation and… Read more »
CBLS Hosts Eli Lilly for Fall Networking Reception
By Rex Rumsey, MBA Candidate, Class of ’25 Back-to-back standout events for Life Sciences at Kelley, thanks to the one-and-only Eli Lilly and Company and an insightful lineup, including Stephen Schenk, Bram Brouwers, and David Birrer! Stephen captured the ambition driving Eli Lilly’s growth, stating that it’s no longer enough for Lilly to be the… Read more »